Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men-Reference-Cited by-同舟云学术

Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men

Published:2022-05-24 Issue:6 Volume:1 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Basourakos Spyridon P.¹,Gulati Roman²,Vince Randy A.³,Spratt Daniel E.⁴⁵,Lewicki Patrick J.¹,Hill Alexander⁶,Nyame Yaw A.⁷,Cullen Jennifer⁵⁸,Markt Sarah C.⁵⁸,Barbieri Christopher E.¹,Hu Jim C.¹,Trapl Erika⁵⁸,Shoag Jonathan E.¹⁵⁶

Affiliation:

1. Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York

2. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle

3. Department of Urology, University of Michigan, Ann Arbor

4. Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland

5. Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland

6. Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland

7. Department of Urology, University of Washington, Seattle

8. Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland

Publisher

Massachusetts Medical Society

Reference34 articles.

1. National Cancer Institute. Surveillance Epidemiology and End Results SEER data and software. 2020 (https://seer.cancer.gov/resources/).

2. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

3. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

4. The prostate cancer conundrum revisited

5. Prostate Cancer Screening Guidelines for Black Men: Spotlight on an Empty Stage

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. National Trends in PSA Cancer Screening With Parallel Investigation of Colorectal Cancer Screening: An Analysis of the CDC Behavioral Risk Factor Surveillance System From 2012 to 2022;Clinical Genitourinary Cancer;2024-12

2. Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer;JAMA Network Open;2024-06-04

3. Recent trends in the incidence of early-onset prostate cancer;European Journal of Cancer Prevention;2024-05-29

4. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States;NEJM Evidence;2024-04-23

5. Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer;Genome Medicine;2024-04-02